Allergy seeks partners as FDA lifts hold on pollen vaccine
13:20 EDT 3 Aug 2012 | SCRIP
The US FDA has confirmed that the 2007 clinical hold placed on Allergy Therapeutics' clinical development programme for its grass pollen allergy vaccine, Pollinex Quattro Grass (0.5ml; also known as Grass MATA MPL), has now been lifted with immediate..
Original Article: Allergy seeks partners as FDA lifts hold on pollen vaccine
More From BioPortfolio on "Allergy seeks partners as FDA lifts hold on pollen vaccine"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
